These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25006347)

  • 1. Myriad and its implications for patent protection of isolated natural products in the United States.
    Wong AY; Chan AW
    Chin Med; 2014; 9():17. PubMed ID: 25006347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of a recent court challenge to the protection of biomarkers as intellectual property.
    Hall SC; Tromp JM; Jortani SA
    Clin Chim Acta; 2011 May; 412(11-12):802-5. PubMed ID: 21315704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of Myriad and Mayo: will advancements in the biological sciences be spurred or disincentivized? (Or was biotech patenting not complicated enough?).
    Gordon J
    Cold Spring Harb Perspect Med; 2014 Dec; 5(5):a020917. PubMed ID: 25502748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent portfolios after myriad, how to fit in those new genes?
    Aceto JF
    ACS Med Chem Lett; 2013 Aug; 4(8):681-3. PubMed ID: 24900729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care?
    Chandrasekharan S; McGuire AL; Van den Veyver IB
    Prenat Diagn; 2014 Oct; 34(10):921-6. PubMed ID: 24989832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patenting nature-a comparative perspective.
    Dreyfuss RC; Nielsen J; Nicol D
    J Law Biosci; 2018 Dec; 5(3):550-589. PubMed ID: 31143455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
    Bergin C
    Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dolly and
    Burk DL
    J Law Biosci; 2015 Nov; 2(3):606-626. PubMed ID: 27774214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Challenges for Patenting and Clinical Trials of Anticancer Compounds from Natural Products: Coherent Review.
    Sahoo A; Mandal AK; Kumar M; Dwivedi K; Singh D
    Recent Pat Anticancer Drug Discov; 2023; 18(4):470-494. PubMed ID: 36336805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The
    Sherkow JS; Cook-Deegan R; Greely HT
    Annu Rev Genomics Hum Genet; 2024 Aug; 25(1):397-419. PubMed ID: 38424474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patenting carboxyformin in the United States: how does it work and what does it mean?
    Sheehan ME; Wagner LF
    J Diabetes Sci Technol; 2013 Mar; 7(2):308-12. PubMed ID: 23566986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patentable invention in biotechnology.
    Rudolph JR
    Biotechnol Adv; 1996; 14(1):17-34. PubMed ID: 14536922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for strengthening patent protection of pharmaceutical inventions in light of federal court decisions.
    Pillai X; Kinney WA
    Curr Top Med Chem; 2010; 10(18):1929-36. PubMed ID: 20615184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseball bats and chocolate chip cookies: the judicial treatment of DNA in the myriad genetics litigation.
    Binnie I; Park-Thompson V
    Cold Spring Harb Perspect Med; 2014 Dec; 5(6):. PubMed ID: 25524722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patent protection of diagnostic technology: will recent US Supreme Court decisions change patent strategy?
    Komatani TS
    Pharm Pat Anal; 2015; 4(5):357-62. PubMed ID: 26451906
    [No Abstract]   [Full Text] [Related]  

  • 16. International Divergence in Gene Patenting.
    Nicol D; Dreyfuss RC; Gold ER; Li W; Liddicoat J; Van Overwalle G
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():519-541. PubMed ID: 30786226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patents for genetically modified animals.
    O'Connor KW
    J Anim Sci; 1993; 71 Suppl 3():34-40. PubMed ID: 8505268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Framing Ethical Concerns and Attitudes towards Human Gene Patents in the Chinese Press.
    Du L; Lin S; Kamenova K
    Asian Bioeth Rev; 2020 Sep; 12(3):307-323. PubMed ID: 33717340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Something more is necessary: are genes and genetic diagnostic tests statutory subject matter for US patents?
    Cockbain J; Sterckx S
    Expert Rev Mol Diagn; 2011 Mar; 11(2):149-58. PubMed ID: 21405966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYRIAD VOICES AGAINST GENE PATENTS IN THE HIGH COURT.
    McCallum L; Faunce T
    J Law Med; 2015 Dec; 23(2):322-9. PubMed ID: 26939499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.